| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | nuclear matrix | 2.39e-04 | 140 | 83 | 5 | GO:0016363 | |
| GeneOntologyCellularComponent | chromosomal region | 2.67e-04 | 421 | 83 | 8 | GO:0098687 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | SNF8 KRT18 UACA ANKRD13C MYO5B OSBPL6 TENM1 PRKCD TAOK1 ROS1 PLCG2 SEPTIN2 | 3.07e-04 | 934 | 83 | 12 | GO:0048471 |
| GeneOntologyCellularComponent | cytoplasmic region | 5.73e-04 | 360 | 83 | 7 | GO:0099568 | |
| GeneOntologyCellularComponent | nuclear periphery | 5.99e-04 | 171 | 83 | 5 | GO:0034399 | |
| GeneOntologyCellularComponent | sex chromosome | 7.11e-04 | 44 | 83 | 3 | GO:0000803 | |
| GeneOntologyCellularComponent | ruffle membrane | 9.05e-04 | 108 | 83 | 4 | GO:0032587 | |
| GeneOntologyCellularComponent | cuticular plate | 1.18e-03 | 13 | 83 | 2 | GO:0032437 | |
| GeneOntologyCellularComponent | ruffle | 1.38e-03 | 206 | 83 | 5 | GO:0001726 | |
| GeneOntologyCellularComponent | leading edge membrane | 1.50e-03 | 210 | 83 | 5 | GO:0031256 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.63e-03 | 431 | 83 | 7 | GO:0031253 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.65e-03 | 317 | 83 | 6 | GO:0032838 | |
| GeneOntologyCellularComponent | spliceosomal complex | 1.66e-03 | 215 | 83 | 5 | GO:0005681 | |
| Domain | Spectrin | 1.21e-04 | 23 | 79 | 3 | PF00435 | |
| Domain | Spectrin_repeat | 2.46e-04 | 29 | 79 | 3 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 3.31e-04 | 32 | 79 | 3 | IPR018159 | |
| Domain | SPEC | 3.31e-04 | 32 | 79 | 3 | SM00150 | |
| Domain | AlbA_2 | 3.66e-04 | 7 | 79 | 2 | PF04326 | |
| Domain | Schlafen | 3.66e-04 | 7 | 79 | 2 | IPR029684 | |
| Domain | Schlafen_AAA_dom | 3.66e-04 | 7 | 79 | 2 | IPR007421 | |
| Domain | Kinase-like_dom | 2.05e-03 | 542 | 79 | 8 | IPR011009 | |
| Domain | SH3 | 2.22e-03 | 216 | 79 | 5 | PS50002 | |
| Domain | SH3_domain | 2.41e-03 | 220 | 79 | 5 | IPR001452 | |
| Domain | Ank | 2.81e-03 | 228 | 79 | 5 | PF00023 | |
| Domain | EF-hand_1 | 3.95e-03 | 152 | 79 | 4 | PF00036 | |
| Domain | ANK | 4.23e-03 | 251 | 79 | 5 | SM00248 | |
| Domain | ANK_REPEAT | 4.38e-03 | 253 | 79 | 5 | PS50088 | |
| Domain | ANK_REP_REGION | 4.45e-03 | 254 | 79 | 5 | PS50297 | |
| Domain | Ankyrin_rpt | 5.07e-03 | 262 | 79 | 5 | IPR002110 | |
| Domain | C2_dom | 5.17e-03 | 164 | 79 | 4 | IPR000008 | |
| Domain | SH3_1 | 5.17e-03 | 164 | 79 | 4 | PF00018 | |
| Domain | EF-hand_7 | 5.61e-03 | 85 | 79 | 3 | PF13499 | |
| Domain | EF-hand-dom_pair | 7.39e-03 | 287 | 79 | 5 | IPR011992 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX15 CDC37 SF3B3 KRT18 MICAL2 FDPS SPTAN1 INTS11 SUPT16H EPB41L5 MACF1 PRKCD ALYREF PLCG2 EXOC2 CBR1 DIS3 HNRNPU | 2.53e-09 | 1353 | 83 | 18 | 29467282 |
| Pubmed | DHX15 CDC37 NCAPD3 EMC3 SF3B3 KRT18 UACA FDPS SPTAN1 SUPT16H ALYREF MRPL45 EXOC2 DENND1A DIS3 HNRNPU SLC27A2 IWS1 | 6.66e-09 | 1440 | 83 | 18 | 30833792 | |
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 1.36e-08 | 182 | 83 | 8 | 32239614 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DHX15 EMC3 SF3B3 OFD1 KRT18 MYO5B SUPT5H SUPT16H MACF1 ALYREF MAP4K4 CBR1 HNRNPU FAM83B ABCB1 | 1.84e-08 | 1024 | 83 | 15 | 24711643 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX15 CDC37 NCAPD3 SF3B3 ATR TRIO SUPT5H SPTAN1 INTS11 SUPT16H PRKCD ALYREF MAP4K4 CBR1 DIS3 HNRNPU SEPTIN2 | 3.70e-08 | 1425 | 83 | 17 | 30948266 |
| Pubmed | Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis. | 3.70e-07 | 116 | 83 | 6 | 37117180 | |
| Pubmed | EMC3 OFD1 KRT18 TRIO MYO5B SUPT5H SPTAN1 INTS11 SUPT16H PTEN CNTROB KNL1 IWS1 | 1.19e-06 | 1049 | 83 | 13 | 27880917 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DHX15 CDC37 SF3B3 KRT18 UACA MYO5B SYNM SPTAN1 SUPT16H ALYREF RSBN1L HNRNPU FAM83B SEPTIN2 | 1.56e-06 | 1257 | 83 | 14 | 36526897 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DHX15 SNF8 CDC37 STRN3 RAP1GDS1 KRT18 SUPT5H FDPS SPTAN1 SUPT16H MACF1 DIS3 HNRNPU IWS1 SEPTIN2 | 1.64e-06 | 1455 | 83 | 15 | 22863883 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DHX15 SF3B3 PTBP2 SUPT5H SPTAN1 INTS11 SUPT16H MACF1 MRPL45 MAP4K4 HNRNPU DNMT3A IWS1 | 1.68e-06 | 1082 | 83 | 13 | 38697112 |
| Pubmed | RAP1GDS1 TRIO SYNM SUPT5H MICAL2 SPTAN1 OLFM1 MACF1 TAOK1 RIPK4 MAP4K4 CBR1 RSBN1L SEPTIN2 | 2.01e-06 | 1285 | 83 | 14 | 35914814 | |
| Pubmed | 2.10e-06 | 156 | 83 | 6 | 22952844 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | EFHC2 TBC1D32 ANKS6 SF3B3 OFD1 MYO5B SUPT5H SUPT16H FBRS OSBPL6 ALYREF EXOC2 DENND1A DIS3 | 2.77e-06 | 1321 | 83 | 14 | 27173435 |
| Pubmed | CDC37 BRCA2 TRIO MYO5B SUPT5H MICAL2 SUPT16H MACF1 CBR1 FAM83B | 2.78e-06 | 634 | 83 | 10 | 34591612 | |
| Pubmed | DHX15 SF3B3 SYNM PTBP2 SUPT5H ALYREF DIS3 HNRNPU IWS1 SEPTIN2 | 3.61e-06 | 653 | 83 | 10 | 33742100 | |
| Pubmed | DHX15 KRT18 UACA SUPT5H SPTAN1 SUPT16H MACF1 ALYREF IWS1 SEPTIN2 | 3.96e-06 | 660 | 83 | 10 | 32780723 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DHX15 CDC37 RAP1GDS1 SF3B3 KRT18 SUPT5H SUPT16H ALYREF CBR1 DIS3 HNRNPU KNL1 IWS1 SEPTIN2 | 4.11e-06 | 1367 | 83 | 14 | 32687490 |
| Pubmed | Pot1a prevents telomere dysfunction and ATM-dependent neuronal loss. | 4.68e-06 | 14 | 83 | 3 | 24899707 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | SNF8 VIL1 RAP1GDS1 UACA MYO5B SLC6A19 PRKCD ALYREF TAOK1 CBR1 SLC27A2 ABCB1 | 5.21e-06 | 1016 | 83 | 12 | 19056867 |
| Pubmed | Novel PKC signaling is required for LPS-induced soluble Flt-1 expression in macrophages. | 5.63e-06 | 2 | 83 | 2 | 18511573 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20467490 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 37802411 | ||
| Pubmed | Management of atypical pneumonias in view of the new entity "Legionnaire's disease". | 5.63e-06 | 2 | 83 | 2 | 276901 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30914801 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 29396668 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 10948194 | ||
| Pubmed | VIL1 STRN3 SF3B3 KRT18 MYO5B PTBP2 SPTAN1 SUPT16H TENM1 MACF1 C2orf78 HNRNPU CFAP46 ABCB1 | 7.56e-06 | 1442 | 83 | 14 | 35575683 | |
| Pubmed | DHX15 VIL1 SPTAN1 SUPT16H MACF1 ALYREF CBR1 HNRNPU SLC27A2 SEPTIN2 | 7.60e-06 | 711 | 83 | 10 | 33022573 | |
| Pubmed | DHX15 CDC37 SF3B3 KRT18 UACA MYO5B MICAL2 FDPS SPTAN1 ALYREF DIS3 HNRNPU FAM83B | 7.82e-06 | 1247 | 83 | 13 | 27684187 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.05e-05 | 120 | 83 | 5 | 31413325 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.06e-05 | 582 | 83 | 9 | 20467437 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 1.12e-05 | 317 | 83 | 7 | 17620599 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | DHX15 NCAPD3 SF3B3 ATR KRT18 SUPT5H INTS11 SUPT16H ALYREF SLFN5 HNRNPU SLC27A2 IWS1 | 1.16e-05 | 1294 | 83 | 13 | 30804502 |
| Pubmed | Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system. | 1.33e-05 | 60 | 83 | 4 | 29055695 | |
| Pubmed | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. | 1.40e-05 | 328 | 83 | 7 | 23398456 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 1.47e-05 | 219 | 83 | 6 | 31353912 | |
| Pubmed | 1.53e-05 | 463 | 83 | 8 | 34901782 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.58e-05 | 774 | 83 | 10 | 15302935 | |
| Pubmed | 1.61e-05 | 63 | 83 | 4 | 37052853 | ||
| Pubmed | Centrobin: a novel daughter centriole-associated protein that is required for centriole duplication. | 1.69e-05 | 3 | 83 | 2 | 16275750 | |
| Pubmed | ATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment. | 1.69e-05 | 3 | 83 | 2 | 28273450 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 17636424 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 38743615 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 24672057 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 24814288 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 25176644 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 9021139 | ||
| Pubmed | ABCB1, ABCG2, and PTEN determine the response of glioblastoma to temozolomide and ABT-888 therapy. | 1.69e-05 | 3 | 83 | 2 | 24647572 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 33504340 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 31940494 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | DHX15 CDC37 STRN3 SF3B3 KRT18 SPTAN1 SUPT16H MACF1 ALYREF CBR1 HNRNPU SEPTIN2 | 1.78e-05 | 1149 | 83 | 12 | 35446349 |
| Pubmed | STRN3 UACA TRIO SPTAN1 SUPT16H MACF1 ALYREF GRIK2 MAP4K4 HNRNPU SEPTIN2 | 1.82e-05 | 963 | 83 | 11 | 28671696 | |
| Pubmed | 2.40e-05 | 493 | 83 | 8 | 15368895 | ||
| Pubmed | 2.40e-05 | 239 | 83 | 6 | 26641092 | ||
| Pubmed | 2.43e-05 | 494 | 83 | 8 | 26831064 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DHX15 EMC3 SF3B3 KRT18 SPTAN1 SUPT16H MACF1 ALYREF EXOC2 CBR1 DIS3 HNRNPU IWS1 | 2.96e-05 | 1415 | 83 | 13 | 28515276 |
| Pubmed | DHX15 STRN3 RAP1GDS1 SF3B3 TRIO MYO5B MICAL2 SPTAN1 OSBPL6 MACF1 CBR1 HNRNPU SEPTIN2 | 3.32e-05 | 1431 | 83 | 13 | 37142655 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 20056007 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 20513533 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 24615332 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 27641736 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 28219950 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 22163289 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 31806642 | ||
| Pubmed | Pten and EphB4 regulate the establishment of perisomatic inhibition in mouse visual cortex. | 3.37e-05 | 4 | 83 | 2 | 27611660 | |
| Pubmed | ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status. | 3.37e-05 | 4 | 83 | 2 | 23548269 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | OFD1 KRT18 TRIO SPTAN1 OSBPL6 EPB41L5 MACF1 MAP4K4 DENND1A FAM83B | 3.91e-05 | 861 | 83 | 10 | 36931259 |
| Pubmed | 4.10e-05 | 263 | 83 | 6 | 34702444 | ||
| Pubmed | Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer. | 4.11e-05 | 28 | 83 | 3 | 24462114 | |
| Pubmed | CDC37 EMC3 SF3B3 OFD1 UACA SYNM SPTAN1 SUPT16H EPB41L5 MACF1 MRPL45 MAP4K4 FAM83B | 4.93e-05 | 1487 | 83 | 13 | 33957083 | |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 5.46e-05 | 169 | 83 | 5 | 23084401 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 18642075 | ||
| Pubmed | A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. | 5.60e-05 | 5 | 83 | 2 | 23435381 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 27422101 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 20889571 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 22806935 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 30846735 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 24332043 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 10912001 | ||
| Pubmed | Cdx2 regulates endo-lysosomal function and epithelial cell polarity. | 6.79e-05 | 33 | 83 | 3 | 20551175 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 8.25e-05 | 588 | 83 | 8 | 38580884 | |
| Pubmed | STRN3 EMC3 TRIO FDPS SPTAN1 TENM1 OLFM1 MACF1 PTEN MAP4K4 HNRNPU | 8.28e-05 | 1139 | 83 | 11 | 36417873 | |
| Pubmed | Early-Life Gene Expression in Neurons Modulates Lasting Epigenetic States. | 8.39e-05 | 6 | 83 | 2 | 29056337 | |
| Pubmed | High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease. | 8.39e-05 | 6 | 83 | 2 | 28608929 | |
| Pubmed | Schlafen, a new family of growth regulatory genes that affect thymocyte development. | 8.39e-05 | 6 | 83 | 2 | 9846487 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | DHX15 SF3B3 BRCA2 KRT18 PTBP2 SUPT16H ALYREF RSBN1L HNRNPU KNL1 | 9.16e-05 | 954 | 83 | 10 | 36373674 |
| Pubmed | 9.60e-05 | 601 | 83 | 8 | 33658012 | ||
| Pubmed | ZNF212 promotes genomic integrity through direct interaction with TRAIP. | 9.60e-05 | 37 | 83 | 3 | 36594163 | |
| Pubmed | 9.73e-05 | 191 | 83 | 5 | 33762435 | ||
| Pubmed | 9.76e-05 | 446 | 83 | 7 | 24255178 | ||
| Pubmed | DHX15 VIL1 UACA SPTAN1 INTS11 SUPT16H EPB41L5 ALYREF TAOK1 ROS1 DENND1A RSBN1L | 9.78e-05 | 1371 | 83 | 12 | 36244648 | |
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | 9.93e-05 | 604 | 83 | 8 | 37616343 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.00e-04 | 605 | 83 | 8 | 28977666 | |
| Pubmed | 1.03e-04 | 101 | 83 | 4 | 10997877 | ||
| Pubmed | 1.03e-04 | 101 | 83 | 4 | 18519826 | ||
| Pubmed | Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly. | 1.04e-04 | 38 | 83 | 3 | 36674791 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.16e-04 | 104 | 83 | 4 | 31240132 | |
| Pubmed | The Calcium Channel Subunit Alpha2delta2 Suppresses Axon Regeneration in the Adult CNS. | 1.17e-04 | 7 | 83 | 2 | 27720483 | |
| Pubmed | Parvalbumin interneuron activity in autism underlies susceptibility to PTSD-like memory formation. | 1.17e-04 | 7 | 83 | 2 | 38741709 | |
| Pubmed | The Spt6 SH2 domain binds Ser2-P RNAPII to direct Iws1-dependent mRNA splicing and export. | 1.17e-04 | 7 | 83 | 2 | 17234882 | |
| Interaction | BRCA1 interactions | DHX15 CDC37 NCAPD3 SF3B3 ATR BRCA2 KRT18 TRIO SUPT5H MICAL2 SPTAN1 SUPT16H ALYREF USH2A MAP4K4 CBR1 HNRNPU KNL1 SEPTIN2 | 5.61e-07 | 1249 | 83 | 19 | int:BRCA1 |
| Interaction | KDF1 interactions | 1.26e-06 | 192 | 83 | 8 | int:KDF1 | |
| Interaction | ECT2 interactions | DHX15 CCDC91 SF3B3 OFD1 MYO5B SPTAN1 SUPT16H EPB41L5 MACF1 ALYREF RIPK4 MRPL45 HNRNPU FAM83B SEPTIN2 | 2.96e-06 | 887 | 83 | 15 | int:ECT2 |
| Interaction | RHOB interactions | RAP1GDS1 UACA TRIO SPTAN1 SUPT16H OSBPL6 EPB41L5 MACF1 PRKCD EXOC2 MAP4K4 HNRNPU FAM83B SEPTIN2 | 7.81e-06 | 840 | 83 | 14 | int:RHOB |
| Interaction | PLEC interactions | 1.07e-05 | 430 | 83 | 10 | int:PLEC | |
| Interaction | EED interactions | DHX15 NCAPD3 SF3B3 KRT18 TRIO MYO5B SUPT5H SPTAN1 SUPT16H MACF1 ALYREF EXOC2 PSPH PTEN CBR1 DIS3 HNRNPU DNMT3A | 1.91e-05 | 1445 | 83 | 18 | int:EED |
| Interaction | RHOF interactions | NCAPD3 RAP1GDS1 EMC3 ATR UACA SPTAN1 SUPT16H EPB41L5 MACF1 MAP4K4 DIS3 FAM83B | 1.93e-05 | 673 | 83 | 12 | int:RHOF |
| Interaction | NELFE interactions | 1.93e-05 | 201 | 83 | 7 | int:NELFE | |
| Interaction | GSK3A interactions | 2.06e-05 | 464 | 83 | 10 | int:GSK3A | |
| Interaction | CDCA5 interactions | 2.46e-05 | 140 | 83 | 6 | int:CDCA5 | |
| Interaction | NEDD1 interactions | 3.55e-05 | 221 | 83 | 7 | int:NEDD1 | |
| Interaction | CDC5L interactions | DHX15 SF3B3 ATR KRT18 TRIO PTBP2 SUPT5H SPTAN1 MACF1 ALYREF EXOC2 HNRNPU KNL1 | 4.45e-05 | 855 | 83 | 13 | int:CDC5L |
| Interaction | KRT18 interactions | 5.63e-05 | 419 | 83 | 9 | int:KRT18 | |
| Interaction | YWHAB interactions | DHX15 CDC37 NCAPD3 KRT18 UACA SPTAN1 OSBPL6 EPB41L5 MACF1 PRKCD TAOK1 RIPK4 DENND1A FAM83B | 6.27e-05 | 1014 | 83 | 14 | int:YWHAB |
| Interaction | DISC1 interactions | 6.74e-05 | 429 | 83 | 9 | int:DISC1 | |
| Interaction | COPE interactions | 7.01e-05 | 334 | 83 | 8 | int:COPE | |
| Interaction | CDKN2A interactions | 7.16e-05 | 335 | 83 | 8 | int:CDKN2A | |
| Interaction | SNRPC interactions | 8.18e-05 | 440 | 83 | 9 | int:SNRPC | |
| Interaction | CDK2 interactions | DHX15 CDC37 RAP1GDS1 SF3B3 OFD1 ATR BRCA2 SPTAN1 SUPT16H ALYREF CNTROB HNRNPU | 8.36e-05 | 783 | 83 | 12 | int:CDK2 |
| Interaction | PPP2R1A interactions | DHX15 CDC37 STRN3 NCAPD3 KRT18 SYNM SUPT5H FDPS INTS11 RIPK4 MAP4K4 | 8.67e-05 | 665 | 83 | 11 | int:PPP2R1A |
| Interaction | EPYC interactions | 1.00e-04 | 4 | 83 | 2 | int:EPYC | |
| Interaction | DIRAS3 interactions | 1.04e-04 | 262 | 83 | 7 | int:DIRAS3 | |
| Interaction | GRK5 interactions | 1.06e-04 | 182 | 83 | 6 | int:GRK5 | |
| Interaction | IWS1 interactions | 1.18e-04 | 116 | 83 | 5 | int:IWS1 | |
| Interaction | H2BC21 interactions | DHX15 SUPT5H INTS11 SUPT16H OSBPL6 TENM1 CASQ2 MAP4K4 HNRNPU CFAP46 IWS1 | 1.30e-04 | 696 | 83 | 11 | int:H2BC21 |
| Interaction | PPP5C interactions | 1.31e-04 | 272 | 83 | 7 | int:PPP5C | |
| Interaction | YWHAH interactions | CDC37 OFD1 KRT18 UACA TRIO SPTAN1 OSBPL6 EPB41L5 MACF1 TAOK1 RIPK4 MAP4K4 DENND1A FAM83B | 1.51e-04 | 1102 | 83 | 14 | int:YWHAH |
| Interaction | YWHAG interactions | DHX15 CDC37 SF3B3 KRT18 UACA SPTAN1 OSBPL6 EPB41L5 MACF1 PRKCD TAOK1 RIPK4 MAP4K4 DENND1A FAM83B | 1.57e-04 | 1248 | 83 | 15 | int:YWHAG |
| Interaction | SNRPA interactions | 1.63e-04 | 482 | 83 | 9 | int:SNRPA | |
| Interaction | PPP2CA interactions | 1.68e-04 | 484 | 83 | 9 | int:PPP2CA | |
| Interaction | CUL7 interactions | DHX15 CDC37 SF3B3 KRT18 SUPT5H SUPT16H MACF1 CASQ2 ALYREF CBR1 HNRNPU ABCB1 | 1.71e-04 | 845 | 83 | 12 | int:CUL7 |
| Interaction | SOX2 interactions | DHX15 PTBP2 SUPT5H SPTAN1 INTS11 SUPT16H FBRS MACF1 PRKCD ALYREF SLFN5 PSPH CBR1 HNRNPU KNL1 SEPTIN2 | 1.97e-04 | 1422 | 83 | 16 | int:SOX2 |
| Interaction | UHRF1 interactions | 2.19e-04 | 208 | 83 | 6 | int:UHRF1 | |
| Interaction | ACIN1 interactions | 2.43e-04 | 301 | 83 | 7 | int:ACIN1 | |
| Interaction | EFTUD2 interactions | DHX15 SNF8 EMC3 SF3B3 KRT18 SUPT5H SPTAN1 SUPT16H MACF1 ALYREF EXOC2 PTEN CBR1 DIS3 HNRNPU IWS1 | 2.44e-04 | 1449 | 83 | 16 | int:EFTUD2 |
| Interaction | PLK1 interactions | 2.48e-04 | 510 | 83 | 9 | int:PLK1 | |
| Interaction | TRIM37 interactions | SF3B3 OFD1 KRT18 SYNM SPTAN1 MAGEB18 ALYREF PTEN CNTROB HNRNPU | 2.59e-04 | 630 | 83 | 10 | int:TRIM37 |
| Interaction | CMTR1 interactions | 2.82e-04 | 218 | 83 | 6 | int:CMTR1 | |
| Interaction | EPB41L4A interactions | 2.83e-04 | 140 | 83 | 5 | int:EPB41L4A | |
| Interaction | KIF23 interactions | DHX15 SF3B3 MYO5B MICAL2 SPTAN1 SUPT16H MACF1 ALYREF PTEN MAP4K4 HNRNPU SLC27A2 FAM83B | 2.88e-04 | 1031 | 83 | 13 | int:KIF23 |
| Interaction | C11orf52 interactions | 2.97e-04 | 311 | 83 | 7 | int:C11orf52 | |
| Interaction | EXOC1 interactions | 3.12e-04 | 143 | 83 | 5 | int:EXOC1 | |
| Interaction | BIRC3 interactions | DHX15 CDC37 SF3B3 ATR TRIO SUPT5H SPTAN1 SUPT16H PRKCD ALYREF RIPK4 CBR1 DIS3 HNRNPU SEPTIN2 | 3.24e-04 | 1334 | 83 | 15 | int:BIRC3 |
| Interaction | NAA16 interactions | 3.36e-04 | 33 | 83 | 3 | int:NAA16 | |
| Interaction | EME2 interactions | 3.47e-04 | 7 | 83 | 2 | int:EME2 | |
| Interaction | KIF20A interactions | DHX15 SAMD9L SF3B3 UACA PTBP2 SPTAN1 SUPT16H MACF1 ALYREF PLCG2 MAP4K4 HNRNPU FAM83B | 3.50e-04 | 1052 | 83 | 13 | int:KIF20A |
| Interaction | POLR2A interactions | 3.57e-04 | 536 | 83 | 9 | int:POLR2A | |
| Interaction | HDGF interactions | 3.59e-04 | 321 | 83 | 7 | int:HDGF | |
| Interaction | SLMAP interactions | 3.77e-04 | 149 | 83 | 5 | int:SLMAP | |
| Interaction | HSPA4 interactions | 4.07e-04 | 667 | 83 | 10 | int:HSPA4 | |
| Interaction | AKT3 interactions | 4.20e-04 | 85 | 83 | 4 | int:AKT3 | |
| Interaction | TPBG interactions | 4.36e-04 | 36 | 83 | 3 | int:TPBG | |
| GeneFamily | Schlafen family | 2.25e-04 | 7 | 60 | 2 | 1110 | |
| GeneFamily | Ankyrin repeat domain containing | 1.24e-03 | 242 | 60 | 5 | 403 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | NCAPD3 KRT18 TRIO MYO5B TENM1 EPB41L5 ROS1 GRIK2 RIPK4 PSPH PTEN SLC27A2 DNMT3A | 1.14e-05 | 801 | 82 | 13 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.41e-05 | 204 | 82 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | BRCA2 ANKRD13C MYO5B PTBP2 SPTAN1 SUPT16H EPB41L5 TAOK1 HNRNPU IWS1 | 3.80e-05 | 532 | 82 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.00e-04 | 192 | 82 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 1.28e-04 | 498 | 82 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 1.39e-04 | 68 | 82 | 4 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.55e-04 | 298 | 82 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_500 | 1.59e-04 | 401 | 82 | 8 | gudmap_developingKidney_e11.5_ureteric bud_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.74e-04 | 72 | 82 | 4 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k4_1000 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 1.97e-06 | 199 | 83 | 6 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.17e-05 | 158 | 83 | 5 | ab05f6d7968ccd6d3826cd71b763dbedc83822c3 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-05 | 174 | 83 | 5 | e7cca4b6a3935fad61cf2a3d9984ab1ffa1a9447 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-05 | 174 | 83 | 5 | ad5b56f0ace6455c033834b931ec870cc0dc9290 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.69e-05 | 188 | 83 | 5 | 340f0e3e65c7a00d82d26621ff37107458bebc41 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.69e-05 | 188 | 83 | 5 | 9d384c0934f1461bc37b1f83e0877d7bee2116ee | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.05e-05 | 193 | 83 | 5 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.05e-05 | 193 | 83 | 5 | 979980369d2dbee9dc4770d72b93037abd7786eb | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-|bone_marrow / Manually curated celltypes from each tissue | 3.13e-05 | 194 | 83 | 5 | 5c58a2d1dd3c8ff77ce44d473239685e6b020909 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.13e-05 | 194 | 83 | 5 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.29e-05 | 196 | 83 | 5 | 541b1fcf509e362f6f48720046cb5378aaf7c591 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.37e-05 | 197 | 83 | 5 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 198 | 83 | 5 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 198 | 83 | 5 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | BAL-Severe|BAL / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.45e-05 | 198 | 83 | 5 | 454aee3f4fe6d0beeccc55200b4495f4f9b44feb | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 3.53e-05 | 199 | 83 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 199 | 83 | 5 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-Treg|Leuk-UTI / Disease, condition lineage and cell class | 3.53e-05 | 199 | 83 | 5 | 100f45e04f284551b29ef0406476bdc347ddbf7e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.53e-05 | 199 | 83 | 5 | 0181c13379f869be47804cdb11bbdabcd30b9b23 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 3.53e-05 | 199 | 83 | 5 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 3.53e-05 | 199 | 83 | 5 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.53e-05 | 199 | 83 | 5 | ee981046217e8759610eb58a670d98f32cd83abc | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.62e-05 | 200 | 83 | 5 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.62e-05 | 200 | 83 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.62e-05 | 200 | 83 | 5 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.62e-05 | 200 | 83 | 5 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.62e-05 | 200 | 83 | 5 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.62e-05 | 200 | 83 | 5 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.62e-05 | 200 | 83 | 5 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Car3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.15e-04 | 134 | 83 | 4 | 4ef5f395e321cf04e56560be2502a8aa157682f4 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-Treg|Leuk-UTI / Disease, Lineage and Cell Type | 1.92e-04 | 153 | 83 | 4 | b24c693b142206d13b29c96faa7f79a1a22bc2ef | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 165 | 83 | 4 | e32697321cef424c2ad4e11ee9da3e510d5ce505 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 165 | 83 | 4 | 0fbdd043e11aa8dbff4cd3a4da1b2feb49878a09 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-04 | 166 | 83 | 4 | 0b4e1d879c61be9d18d7aac51e5115f103f51209 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.74e-04 | 168 | 83 | 4 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 172 | 83 | 4 | b26fc612f232e8e273825ac2d2e5519cbb7322cf | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.00e-04 | 172 | 83 | 4 | f0b658baa4b41329c95a09387cc55ea046e2333f | |
| ToppCell | control-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.06e-04 | 173 | 83 | 4 | 0c9fb18536ddd61b51b7bb4d40841f67b017f360 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 175 | 83 | 4 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.41e-04 | 178 | 83 | 4 | 3d120458a0a56097532ebfa5fc6f77b52af2af2a | |
| ToppCell | Globus_pallidus-Macroglia|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.48e-04 | 179 | 83 | 4 | ab50f711b004b96107f813c9a2526ec21d1c8027 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 3.48e-04 | 179 | 83 | 4 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.56e-04 | 180 | 83 | 4 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 181 | 83 | 4 | 89c551de26de047c316c91ac1d97bdf728a33d9e | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.63e-04 | 181 | 83 | 4 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-04 | 182 | 83 | 4 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 183 | 83 | 4 | 6cdadb3ece45a94a2915063aa461048e1d371ccd | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.79e-04 | 183 | 83 | 4 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-04 | 183 | 83 | 4 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.79e-04 | 183 | 83 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-04 | 183 | 83 | 4 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo|bone_marrow / Manually curated celltypes from each tissue | 3.79e-04 | 183 | 83 | 4 | 2fb78622adc170dd3301e251418337523de50faf | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 183 | 83 | 4 | 8714d3e7663c93cdf9b25b647353572e136f30c3 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 183 | 83 | 4 | ecac1cfaff7553a60305b34d6cede6973ffb5430 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 183 | 83 | 4 | c7fc96ac1d5d31ccefe0c1fc6ec76c7d8607a172 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|bone_marrow / Manually curated celltypes from each tissue | 3.79e-04 | 183 | 83 | 4 | 37db007cc65005bffc18a5fda7f454a57c9fb0a9 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 183 | 83 | 4 | f6ebfd7f61e912f92bd07313cc213a171747ac03 | |
| ToppCell | (7)_Epithelial-H_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.87e-04 | 184 | 83 | 4 | 1f76b37c265b519171b767a52d48f31f0cdc4a3c | |
| ToppCell | E12.5-Epithelial-airway_epithelial_cell-club_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.87e-04 | 184 | 83 | 4 | a69c3c57cd939b2888f548a0fbca3392ad310445 | |
| ToppCell | E12.5-Epithelial-airway_epithelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.87e-04 | 184 | 83 | 4 | 3df78b17098b50e1a7f2c8791bf2d0806328330a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-04 | 184 | 83 | 4 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-04 | 184 | 83 | 4 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-04 | 185 | 83 | 4 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.95e-04 | 185 | 83 | 4 | 9d424a8608b339dd6129c58d87626678d4ec4af7 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 4.03e-04 | 186 | 83 | 4 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.03e-04 | 186 | 83 | 4 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 4.03e-04 | 186 | 83 | 4 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.11e-04 | 187 | 83 | 4 | c2940aec30b3c2c113f6a65126dc6f1969cf301e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.11e-04 | 187 | 83 | 4 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|IPF / Disease state, Lineage and Cell class | 4.11e-04 | 187 | 83 | 4 | 19d6a404fc3651d98a93e3848e372df51a239c57 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-04 | 187 | 83 | 4 | 3ca3954f45f167e98a230f2847f0582d74fcd32e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-04 | 187 | 83 | 4 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.19e-04 | 188 | 83 | 4 | d00f48afed62fc60d3530bb3b80ac0162b0b0ed8 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-04 | 188 | 83 | 4 | b483b4629695764568bcbd1d527d614824147783 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.19e-04 | 188 | 83 | 4 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.19e-04 | 188 | 83 | 4 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-04 | 188 | 83 | 4 | c1f64311ff05093b2f4f672e33f5f75e3bc8a8db | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 4.19e-04 | 188 | 83 | 4 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.28e-04 | 189 | 83 | 4 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.28e-04 | 189 | 83 | 4 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | PND10-Epithelial-Epithelial_Airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.28e-04 | 189 | 83 | 4 | 407d8a59969d83f014600aae1a55092283a13970 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 4.28e-04 | 189 | 83 | 4 | 8030a353473da34ae92429f2d822171a2e94248f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.28e-04 | 189 | 83 | 4 | 5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169 | |
| ToppCell | (2)_NK/T-(210)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 4.28e-04 | 189 | 83 | 4 | fa72e87e1e8cd7cbddae7b47e19cf90d181820a7 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.28e-04 | 189 | 83 | 4 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | (2)_NK/T-(21)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 4.28e-04 | 189 | 83 | 4 | b37ad24898a14a4a3b2d6cea2637de2471f76e20 | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 4.36e-04 | 190 | 83 | 4 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.36e-04 | 190 | 83 | 4 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.36e-04 | 190 | 83 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.36e-04 | 190 | 83 | 4 | 9f5f65869dad9a43ac94f81f9a19c72ffe5adc3c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.45e-04 | 191 | 83 | 4 | f1935e8f8467a2bc30588b7f2cc3b94e9c83b268 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.45e-04 | 191 | 83 | 4 | 1161e465c50c2071764279e01cf08b1048cce0e3 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.45e-04 | 191 | 83 | 4 | ce76b156b153a2c7c9f2fb8e563b69c81073fbe5 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.45e-04 | 191 | 83 | 4 | c006f5a6e3a32b79ac99a78304bdd5116fc0d5e0 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.45e-04 | 191 | 83 | 4 | 7a4fe96989f72159385270c712342ba3e1ca6fc3 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.45e-04 | 191 | 83 | 4 | 588015d76b68488da6aa6603777682f3d81592bf | |
| ToppCell | Control-Lymphoid_T/NK-NK_CD56bright|Control / Disease group, lineage and cell class | 4.45e-04 | 191 | 83 | 4 | e842f29bc03ed6734b2a7b975e7830a498f2743c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.45e-04 | 191 | 83 | 4 | c023ca893ceae19b54967096f6e2588dc39fa268 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.45e-04 | 191 | 83 | 4 | 4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6 | |
| ToppCell | (210)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 4.54e-04 | 192 | 83 | 4 | 08dc0c019c594da7b9944db8fd706aa7780e6ae9 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.19e-04 | 50 | 55 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Computational | Genes in the cancer module 417. | 1.82e-04 | 22 | 55 | 3 | MODULE_417 | |
| Disease | Squamous cell carcinoma of oropharynx | 4.67e-05 | 4 | 83 | 2 | C0280313 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 5.95e-05 | 239 | 83 | 6 | EFO_0010934 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 7.44e-05 | 29 | 83 | 3 | C0496920 | |
| Disease | Ovarian Carcinoma | 8.25e-05 | 30 | 83 | 3 | C0029925 | |
| Disease | Glioma | 1.08e-04 | 87 | 83 | 4 | C0017638 | |
| Disease | endometrial cancer (implicated_via_orthology) | 2.16e-04 | 8 | 83 | 2 | DOID:1380 (implicated_via_orthology) | |
| Disease | serum albumin measurement | 2.64e-04 | 592 | 83 | 8 | EFO_0004535 | |
| Disease | Intellectual Disability | 2.69e-04 | 447 | 83 | 7 | C3714756 | |
| Disease | Malignant tumor of prostate | 2.78e-04 | 9 | 83 | 2 | cv:C0376358 | |
| Disease | Malignant neoplasm of kidney | 2.80e-04 | 45 | 83 | 3 | C0740457 | |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 3.60e-04 | 49 | 83 | 3 | DOID:684 (implicated_via_orthology) | |
| Disease | neuritic plaque measurement | 4.60e-04 | 349 | 83 | 6 | EFO_0006798 | |
| Disease | ossification of the posterior longitudinal ligament of the spine | 5.07e-04 | 12 | 83 | 2 | EFO_0005895 | |
| Disease | ovarian neoplasm | 5.66e-04 | 134 | 83 | 4 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 6.15e-04 | 137 | 83 | 4 | C1140680 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 6.96e-04 | 14 | 83 | 2 | C0677776 | |
| Disease | Malignant neoplasm of liver | 7.04e-04 | 142 | 83 | 4 | C0345904 | |
| Disease | Liver neoplasms | 7.04e-04 | 142 | 83 | 4 | C0023903 | |
| Disease | hyperinsulinism (biomarker_via_orthology) | 8.02e-04 | 15 | 83 | 2 | DOID:2018 (biomarker_via_orthology) | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 9.14e-04 | 16 | 83 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | breast size | 9.84e-04 | 69 | 83 | 3 | EFO_0004884 | |
| Disease | Non-Small Cell Lung Carcinoma | 9.99e-04 | 156 | 83 | 4 | C0007131 | |
| Disease | colorectal cancer (is_marker_for) | 1.02e-03 | 157 | 83 | 4 | DOID:9256 (is_marker_for) | |
| Disease | Malignant Glioma | 1.03e-03 | 70 | 83 | 3 | C0555198 | |
| Disease | mixed gliomas | 1.03e-03 | 70 | 83 | 3 | C0259783 | |
| Disease | Inborn Errors of Metabolism | 1.03e-03 | 17 | 83 | 2 | C0025521 | |
| Disease | Malignant neoplasm of endometrium | 1.16e-03 | 18 | 83 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 1.16e-03 | 18 | 83 | 2 | C0346191 | |
| Disease | Adenocarcinoma of prostate | 1.44e-03 | 20 | 83 | 2 | C0007112 | |
| Disease | left atrial function | 1.59e-03 | 21 | 83 | 2 | EFO_0004294 | |
| Disease | Seckel syndrome | 1.74e-03 | 22 | 83 | 2 | C0265202 | |
| Disease | Autosomal Recessive Primary Microcephaly | 1.74e-03 | 22 | 83 | 2 | C3711387 | |
| Disease | Carcinoma of lung | 1.90e-03 | 23 | 83 | 2 | C0684249 | |
| Disease | Neoplasm of the genitourinary tract | 2.07e-03 | 24 | 83 | 2 | cv:C0042065 | |
| Disease | breast cancer (implicated_via_orthology) | 2.25e-03 | 25 | 83 | 2 | DOID:1612 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 2.32e-03 | 93 | 83 | 3 | C1535926 | |
| Disease | non-alcoholic fatty liver disease (is_marker_for) | 2.62e-03 | 27 | 83 | 2 | DOID:0080208 (is_marker_for) | |
| Disease | Malignant tumor of breast | 2.62e-03 | 27 | 83 | 2 | cv:C0006142 | |
| Disease | Breast neoplasm | 2.62e-03 | 27 | 83 | 2 | cv:C1458155 | |
| Disease | Sezary Syndrome | 2.62e-03 | 27 | 83 | 2 | C0036920 | |
| Disease | Familial cancer of breast | 2.62e-03 | 27 | 83 | 2 | cv:C0346153 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KMIRKGVFKDQHFDQ | 911 | Q13523 | |
| MAENSKFFKKHGIRN | 421 | P41595 | |
| VFHALGKKIDMKTGF | 636 | A6NCI8 | |
| KQGKDQHFPVFMNEK | 841 | Q9Y6K1 | |
| IMLGDKEKTFQFLHQ | 1076 | Q96NH3 | |
| FKHFNKLREFVQMKL | 476 | Q8N6S4 | |
| FKHMVIVKAKLGQNF | 1151 | Q8IYW2 | |
| AKKAADEAKMRFAHI | 606 | O43143 | |
| NIKRGKHMDFLSDFE | 516 | Q96ST2 | |
| SDKENQKGFLMHFLK | 131 | O75665 | |
| NHDELMKEKGIYFKL | 611 | P08183 | |
| ELGKFAVFVHAKMAE | 636 | Q8IW93 | |
| IDGKEKNMHSARFKN | 441 | Q8N7Z5 | |
| HKFMAFKSFGELVHK | 1056 | O95819 | |
| LFMKKNHEEEVKGLQ | 211 | P05783 | |
| GDMIKFVIRKDKCHF | 131 | Q96M61 | |
| LLVHGEAKKMEFLKQ | 411 | Q5TA45 | |
| HIKIADFGMCKENIF | 486 | Q05655 | |
| HANAKKILLEMGEFF | 291 | P14324 | |
| AKFHGKMEQKFLLVD | 221 | Q5T0W9 | |
| DMDFLIALAHEKFKK | 616 | Q5JST6 | |
| IALAHEKFKKNMFEN | 621 | Q5JST6 | |
| KGIKQEAFKDMYDLH | 226 | Q99645 | |
| KSKFSQKDLEMLFHG | 141 | Q96KP1 | |
| HLARQFKAIKAKMDE | 146 | Q99784 | |
| KDLPEHAVLKMKGNF | 626 | Q00839 | |
| NLMDAHKVFQKELGK | 2826 | O94854 | |
| IKFHSAAMDEKVIGK | 1271 | Q8NG31 | |
| KFLKDKFVEIGAHKD | 181 | P16885 | |
| HMAKAFKEVFGDLLL | 416 | P16885 | |
| MEENNLEHIPKFFKK | 886 | Q9BZF3 | |
| MDAHKVFQKELGKRT | 6701 | Q9UPN3 | |
| HGKPVKNALDLKFDM | 241 | Q13093 | |
| FFKHQADMLLHGIKV | 271 | Q9NWS6 | |
| KDKFKAERIMVEGFH | 221 | P20848 | |
| AIHMKKSLEKFVGDA | 2201 | Q13535 | |
| THFKMLKKLVEEATF | 2241 | Q13535 | |
| KKAKGQELFDQIMYH | 61 | Q9HCM4 | |
| QEKMKGDSHKLDFRN | 101 | Q9HAH7 | |
| EHNIKKSKMFFKDIE | 1021 | P51587 | |
| VSLFMIHKDGNDFKE | 461 | Q8TD57 | |
| SLMEKHNVLEKGFLK | 161 | Q7Z6B0 | |
| FVEKYEKQIKHFGML | 151 | Q16543 | |
| KDHLKKFNELMVTFR | 91 | Q99807 | |
| LFKKQIEHDKREMIF | 231 | P52306 | |
| IFHALKMGNFQLVKE | 296 | Q68DC2 | |
| LMNKFVEDTKKGVHQ | 171 | P16152 | |
| YKFAKDHAKMGIKEV | 431 | Q8TEH3 | |
| HKAIGFVMVDAKKEA | 86 | O14958 | |
| LMAKDLHFEGMFKKE | 241 | Q9P0I2 | |
| KEMKRGKEFHVIFDC | 216 | Q13002 | |
| LFEGMKAFKGKDQQV | 101 | O15382 | |
| NLKKKDGSKHIFEME | 86 | Q8N137 | |
| HKIQEGDFKNMLRLK | 276 | Q6UXK5 | |
| KNIKEKAAHLASMFG | 866 | O94851 | |
| GDIKVEFFHKQNKML | 251 | P60484 | |
| MDGKNVKAKLDHVQF | 781 | Q6PCB5 | |
| QKGFVGCLKDVHFMK | 1666 | O75445 | |
| EDRHIKFFDNKTGKM | 701 | Q13033 | |
| VDRFNKDIEFMIGHK | 511 | Q695T7 | |
| KTFMQGEFLKIKHIV | 646 | P0C7P3 | |
| TVKAFKFFQDHKMAL | 481 | Q9UKA9 | |
| HREQGKEQAMFDKKV | 1516 | O15061 | |
| KTEKEFMQHARKAGL | 51 | Q9BRJ2 | |
| SKAAFIDHFNVMIKK | 256 | Q8IVG5 | |
| MKENHEFDGKKLFQH | 531 | O14975 | |
| KMKKLLFQEAHNGPA | 311 | Q7L7X3 | |
| NFAAEMEKLIKKHQA | 506 | Q7L7X3 | |
| QFDFVKLMDGKQLVK | 456 | Q9UKZ4 | |
| QELRKYFKMGDHVKV | 466 | O00267 | |
| EMRHKLKTAFKNFIE | 771 | Q9Y5B9 | |
| KPFADEKNILHIMVK | 221 | P57078 | |
| FHVFDKVKVKIMLDS | 901 | Q9Y2L1 | |
| DMFKTNLEEFASKHK | 41 | Q96H20 | |
| FIDEFNGLHMSKDKR | 51 | Q8N8U2 | |
| PFNKKGSAVFHEIKM | 556 | O75339 | |
| QKFLKHKFLVQEIMF | 436 | P42695 | |
| QEKKGAMSHALNFIK | 306 | P09327 | |
| KEKFHFKKIIMIGDG | 166 | P78330 | |
| MFKHFDKDKSGRLNH | 2331 | Q13813 | |
| KVFHMLDKDKSGFIE | 46 | P20472 | |
| KIEFLKEAHLMSKFN | 1991 | P08922 | |
| KNMFEKIHQETFGKS | 96 | Q15393 | |
| GKVKQMQTHFLALKE | 511 | Q9BZF9 | |
| KPLDVAFMKAIHNKV | 161 | Q15019 | |
| LDKMQKENHFLIFVK | 86 | Q08AF3 | |
| DDMKGKDKIVFGNIH | 2006 | O75962 | |
| VHFERKADALKAMKQ | 151 | Q86V81 | |
| GIKKVLKKHNDDFEM | 1531 | Q9ULV0 |